Adaptive immunity after cell death

Trends in Immunology

Volumn 34, Issue 7, 2013, Pages 329-335

  Zelenay, Santiago ^a   Reis e Sousa, Caetano ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

adjuvant; dead cell; infection; inflammation; injury

Indexed keywords

BETA GLUCAN; CHAPERONIN 60; DECTIN 1; DOUBLE STRANDED RNA; FLAGELLIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 33; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE; TENASCIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ANTIGENICITY; APOPTOSIS; CELL DEATH; CELL STRUCTURE; INFLAMMATION; INNATE IMMUNITY; NONSTERILE INFLAMMATION; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PHAGOCYTOSIS; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; APOPTOSIS; CELL DEATH; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFECTION; LYMPHOCYTE ACTIVATION; RECEPTORS, SCAVENGER; WOUNDS AND INJURIES;

EID: 84880849460     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.03.005     Document Type: Review

References (88)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
2. Tauber A.I. Metchnikoff and the phagocytosis theory. Nat. Rev. Mol. Cell Biol. 2003, 4:897-901.
3. Gordon S. Elie Metchnikoff: father of natural immunity. Eur. J. Immunol. 2008, 38:3257-3264.
4. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 2005, 6:1191-1197.
5. Fadok V.A., Chimini G. The phagocytosis of apoptotic cells. Semin. Immunol. 2001, 13:365-372.
6. Juncadella I.J., et al. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 2013, 493:547-551.
7. Rock K.L., et al. Innate and adaptive immune responses to cell death. Immunol. Rev. 2011, 243:191-205.
8. Green D.R., et al. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 2009, 9:353-363.
9. Kroemer G., et al. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 2012, 31:51-72.
10. Sancho D., Reis e Sousa C. Sensing of cell death by myeloid C-type lectin receptors. Curr. Opin. Immunol. 2013, 25:46-52.
11. Nystrom S., et al. TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J. 2013, 32:86-99.
12. Kaczmarek A., et al. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
13. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54:1-13.
14. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
15. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
16. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
17. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
18. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469-478.
19. Marichal T., et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med. 2011, 17:996-1002.
20. Casares N., et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 2005, 202:1691-1701.
21. Obeid M., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 2007, 13:54-61.
22. Apetoh L., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007, 13:1050-1059.
23. Ghiringhelli F., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 2009, 15:1170-1178.
24. Shi Y., et al. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425:516-521.
25. Tewary P., et al. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 2010, 116:3465-3474.
26. Kazama H., et al. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29:21-32.
27. Tang D., et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310.
28. Luthi A.U., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
29. Young G.R., et al. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 2012, 491:774-778.
30. Honda K., Littman D.R. The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 2012, 30:759-795.
31. Yanai H., et al. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol. 2012, 33:633-640.
32. Yamasaki S., et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 2008, 9:1179-1188.
33. Yamasaki S., et al. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1897-1902.
34. Wells C.A., et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 2008, 180:7404-7413.
35. Ishikawa E., et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 2009, 206:2879-2888.
36. Marshak-Rothstein A., Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 2007, 25:419-441.
37. Schroder K., et al. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
38. Strowig T., et al. Inflammasomes in health and disease. Nature 2012, 481:278-286.
39. Means T.K., et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 2005, 115:407-417.
40. Vollmer J., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 2005, 202:1575-1585.
41. Lande R., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
42. Ganguly D., et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 2009, 206:1983-1994.
43. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 2010:672395.
44. Silva E., et al. HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med. 2007, 33:1829-1839.
45. Midwood K., et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 2009, 15:774-780.
46. Osterloh A., et al. Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide. J. Biol. Chem. 2007, 282:4669-4680.
47. Taylor K.R., et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 2007, 282:18265-18275.
48. Germain R.N., Stefanova I. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu. Rev. Immunol. 1999, 17:467-522.
49. Chen G.Y., et al. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009, 323:1722-1725.
50. Sancho D., et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009, 458:899-903.
51. Satpathy A.T., et al. Re(de)fining the dendritic cell lineage. Nat. Immunol. 2012, 13:1145-1154.
52. Ahrens S., et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012, 36:635-645.
53. Zhang J.G., et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012, 36:646-657.
54. + dendritic cells and a subset of monocytes. J. Biol. Chem. 2008, 283:16693-16701.
55. Sancho D., Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 2012, 30:491-529.
56. Zelenay S., et al. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J. Clin. Invest. 2012, 122:1615-1627.
57. Iborra S., et al. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J. Clin. Invest. 2012, 122:1628-1643.
58. Burgdorf S., et al. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316:612-616.
59. + T cells. Cell Death Differ. 2009, 16:991-1005.
60. Rawson P.M., et al. Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat. Med. 2007, 13:1431-1439.
61. Schulz O., et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005, 433:887-892.
62. Torchinsky M.B., et al. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 2009, 458:78-82.
63. Bonilla W.V., et al. The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses. Science 2012, 335:984-989.
64. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
65. Yang D., et al. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J. Exp. Med. 2012, 209:157-171.
66. Tsan M.F., Gao B. Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J. Endotoxin Res. 2007, 13:6-14.
67. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J. Leukoc. Biol. 2010, 87:989-999.
68. Lamkanfi M., Dixit V.M. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 2010, 8:44-54.
69. Yatim N., Albert M.L. Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity. Immunity 2011, 35:478-490.
70. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 2011, 29:139-162.
71. Martinon F., et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
72. Boule M.W., et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 2004, 199:1631-1640.
73. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
74. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
75. Chen C.J., et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 2007, 13:851-856.
76. Eigenbrod T., et al. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J. Immunol. 2008, 181:8194-8198.
77. Hofmann M.A., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
78. Yan S.D., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
79. Halle A., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9:857-865.
80. Stewart C.R., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
81. Niethammer P., et al. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009, 459:996-999.
82. Yoo S.K., et al. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 2011, 480:109-112.
83. Jiang D., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11:1173-1179.
84. Jiang D., et al. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
85. Johnson G.B., et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 2002, 168:5233-5239.
86. Schaefer L., et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 2005, 115:2223-2233.
87. Kim S., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
88. Zhang Q., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.